Clinical Trials Logo
  1. Home
  2. Digestive System Disease
  3. NCT03455595
  4. Details
NCT03455595 Clinical Trial

CONECCT (Colorectal Neoplasia Endoscopic Classification To Chose the Endoscopic Treatment)

Digestive System Disease Clinical Trial

Official title:
CONECCT Score so as to Improve the Diagnosis and the Treatment of Colorectal Neoplasia

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03455595
Other study ID # CONECCT
Secondary ID
Status Completed
Phase N/A
First received February 28, 2018
Last updated March 9, 2018
Start date February 1, 2017
Est. completion date February 1, 2018

Study information
Verified date February 2018
Source Hôpital Edouard Herriot
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Prospective study so as to evaluate CONECCT score to determine both histological tissue and therapeutic choice

Recruitment information / eligibility
Status Completed
Enrollment 60
Est. completion date February 1, 2018
Est. primary completion date February 1, 2018
Accepts healthy volunteers
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

Exclusion Criteria:

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• Endoscopic exams
Coloscopy

Locations
Country Name City State
France Edouard Herriot Hospital Lyon Rhône Alpes

Sponsors (1)
Lead Sponsor Collaborator
Hôpital Edouard Herriot

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Evaluation of the CONECCT endoscopic score so as to improve colon therapeutic treatment polyps There are recognized diagnostic criteria so as to predict the histology of colorectal lesions and thus to choose the right therapy. For the moment, these criteria are scattered in at least 5 different classifications and the CONECCT tool will allow gastroenterology interns to more easily predict the histology of the lesion and so to improve the management of them. one year
See also
  Status Clinical Trial Phase
Recruiting NCT05066139 - Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G) N/A
Recruiting NCT04475952 - Early Diagnosis of Upper Digestive Tract Disease
Completed NCT05064163 - SROI Project on the Surgical Waiting List Management System
Completed NCT03559543 - Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma Phase 2
Completed NCT03549494 - Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction Phase 2
Completed NCT03723447 - Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) Phase 4
Enrolling by invitation NCT01483248 - Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis Phase 1/Phase 2
Completed NCT03008460 - Efficacy, Safety and Tolerability of Eziclen®/Izinova® Versus Klean-prep® on Bowel Cleansing in Adolescents Undergoing Colonoscopy Phase 3
Active, not recruiting NCT05253859 - CFTR Modulators and Gastrointestinal Complications
Not yet recruiting NCT05636657 - Comparative Study of Intestinal Color Ultrasound and Capsule Endoscopy in Monitoring Crohn's Disease
Completed NCT05160077 - Optoacoustic Characterization of Postprandial Intestinal Blood Flow N/A
Recruiting NCT05401058 - Low-dose Droperidol for Prevention of Postoperative Delirium in Elderly Patients After Non-cardiac Surgery N/A
Completed NCT06283732 - A Clinical Study to Assess the Effect of a Supplement on Digestive Health, Overall Well-being, and Participant Experience. N/A
Not yet recruiting NCT06271538 - Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome Phase 4
Terminated NCT03594331 - Gastric Gluten-Degradation Activity of PvP001 Phase 1
Not yet recruiting NCT05405842 - Transauricular Vagal Nerve Stimulation; Functional Dyspepsia and Gastroparesis N/A
Completed NCT02785783 - Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection N/A
Completed NCT00072943 - A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease Phase 2
Completed NCT03037385 - Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors Phase 1/Phase 2
Completed NCT05827679 - Creation and Validation of a Clinical Evaluation Scale for Abdominal Condition of the Premature (ECAP)